LintonPharm Announces Authorization From China Health Authority to Proceed With a Global Phase 3 Trial Evaluating Catumaxomab in Advanced Gastric Cancer
GUANGZHOU, China, July 16 (Bernama-BUSINESS WIRE) — LintonPharm Co. Ltd., a China-based clinical stage biopharmaceutical company focused on the development of…


